Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor, Black sunshine
Search This Board: 
Last Post: 11/13/2018 12:59:55 AM - Followers: 105 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline: 
News and Press Releases: 


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes


yes November 8, 2016  yes



From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting 11/10/2018 08:01:00 AM
CLDX News: Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunot... 11/09/2018 08:01:00 AM
CLDX News: Quarterly Report (10-q) 11/07/2018 04:12:30 PM
CLDX News: Current Report Filing (8-k) 11/07/2018 04:03:15 PM
CLDX News: Celldex Provides Corporate Update and Reports Third Quarter 2018 Results 11/07/2018 04:01:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#1677  Sticky Note Why this Bio-Tech company will file the Bankruptcy ? Value_Investor 11/01/18 10:53:05 AM
#1689   Cldx junk going bankrupt! Liquidations will follow, management harry crumb 11/13/18 12:59:55 AM
#1687   * * $CLDX Video Chart 11-08-18 * * ClayTrader 11/08/18 05:14:50 PM
#1686   Haha CLDX .37+ DD 11/08/18 02:44:52 PM
#1685   Are you sure This Biggest Pos Scam will Value_Investor 11/08/18 10:53:06 AM
#1684   CLDX .33 x .3349. Your numbers are wrong DD 11/07/18 10:38:37 AM
#1683   The Pos Scam crashed to $0.311 so far! Value_Investor 11/07/18 10:29:20 AM
#1682   Yes bankruptcy next! They have zero drugs, zero harry crumb 11/05/18 09:05:00 PM
#1681   CLDX will shine.....the shorts are getting nervous DD 11/05/18 12:34:10 PM
#1680   CLDX has already declined to $0.3252 from today's Value_Investor 11/05/18 11:49:34 AM
#1679   CLDX good entry point here with reporting coming DD 11/05/18 11:28:49 AM
#1678   CLDX has Very Bad News today --- Insider's Sell! Value_Investor 11/02/18 09:27:33 AM
#1677   Why this Bio-Tech company will file the Bankruptcy ? Value_Investor 11/01/18 10:53:05 AM
#1676   Well, the Pos Scam is up to $0.35 Value_Investor 10/31/18 11:45:07 AM
#1675   Predicted .25, an this junk is almost there! harry crumb 10/30/18 12:50:36 PM
#1674   The Pos Scam just hit a New 52-week Value_Investor 10/30/18 10:27:53 AM
#1673   I got stopped out long ago. Just been stockboy 10/30/18 12:30:33 AM
#1672   The Pos Scam just hit a New 52-week Value_Investor 10/29/18 04:18:57 PM
#1671   Please delist this junk so we dont have harry crumb 10/29/18 03:36:47 PM
#1670   Their science is extremely negative, nothing they try harry crumb 10/25/18 04:36:59 PM
#1667   Need some good news Black sunshine 10/23/18 12:31:34 PM
#1666   Will add later on any weakness Black sunshine 10/23/18 12:30:57 PM
#1665   Let's see if this pos is close to bottoming Black sunshine 10/23/18 12:30:30 PM
#1664   In 5k shares @ .36 Black sunshine 10/23/18 12:29:55 PM
#1663   Going bankrupt w/$114 million. Sure. beachboy3 10/22/18 02:47:22 PM
#1662   Weweeeee, made huge wealth here,, covered an long harry crumb 10/22/18 10:20:46 AM
#1661   Bottomed in the low 0,40´s, I´m going to Klinsmann 10/17/18 10:35:05 AM
#1660   Hope u got a short position, this pos harry crumb 10/17/18 08:53:11 AM
#1659   Getting in this week. Chunky Salsa 10/08/18 03:13:13 PM
#1658   Lets finally get this junk to .25 an harry crumb 09/11/18 02:44:55 PM
#1657   * * $CLDX Video Chart 08-22-18 * * ClayTrader 08/22/18 04:27:15 PM
#1656   Lets get this junk to .25 an be harry crumb 08/16/18 09:57:14 PM
#1655   Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates ProfitScout 08/13/18 10:15:14 AM
#1654   $CLDX Not responding well to earnings earlier, despite THREE-DAY-TRADER 08/09/18 12:52:41 PM
#1653   Celldex Provides Corporate Update and Reports Second Quarter ProfitScout 08/08/18 05:55:18 PM
#1652   I've been specifically speaking about Risk or earnings THREE-DAY-TRADER 08/07/18 02:39:32 PM
#1651   It´s mostly a gamble in such biotechs imo Klinsmann 08/07/18 02:36:03 PM
#1650   I just would not trust $CLDX in this THREE-DAY-TRADER 08/07/18 02:33:54 PM
#1649   The good part (which makes it a solid Klinsmann 08/07/18 12:46:11 PM
#1648   Yes, it is showing some stability since low THREE-DAY-TRADER 08/07/18 12:37:11 PM
#1647   Could be time to re-enter again as it Klinsmann 08/07/18 12:11:39 PM
#1646   I warned about this deteriorating since I stopped THREE-DAY-TRADER 08/02/18 10:43:38 PM
#1645   Still on watch, maybe times gonna change into Klinsmann 08/02/18 01:21:02 PM
#1644   Celldex to Report Second Quarter 2018 Financial Results ProfitScout 08/02/18 10:29:42 AM
#1643   Looking good to .25! Keep shorting here, every harry crumb 08/01/18 04:52:34 PM
#1642   4 weeks, this is .25! Wwweeeeee harry crumb 07/30/18 12:37:21 AM
#1641   Been telling people its junk and wont go harry crumb 07/28/18 11:58:52 AM
#1640   Starting to show worsening signs since 7/23 all THREE-DAY-TRADER 07/24/18 12:36:39 PM
#1639   Celldex Therapeutics (NASDAQ: CLDX) was founded based on ProfitScout 07/24/18 09:43:22 AM
#1638   Cldx will never c $1 again without the harry crumb 07/23/18 05:21:56 PM
#1637   Still on watch. Going to have its days imo... Klinsmann 07/19/18 04:33:21 PM